We previously have shown that 6 h of restraint stress in intact male rhesus macaques (Macaca mulatta) suppresses plasma levels of both LH and testosterone and that this effect lasts beyond the period of restraint. Since corticotropin-releasing hormone (CRH) inhibits both the GnRH pulse generator and LH release in ovariectomized macaques and is generally thought to be the central mediator of stress-induced inhibition of gonadotropin release, we investigated the influence of CRH administration on LH and testosterone in unrestrained intact male rhesus macaques. Blood samples were collected from 5 intact male macaques at 15-min intervals for 15 h from a remote site. During this time, each animal received a 4-h infusion of CRH (100-Ig bolus followed by 100 jig/h for 4 h) through an indwelling jugular catheter. Blood samples were collected for an additional 8 h after cessation of the CRH infusion. ACTH and cortisol levels were significantly elevated during and after the CRH infusion and were comparable to levels observed during restraint. Although LH levels appeared lower in animals given CRH, they were not different from those in untreated control males. In some animals, CRH appeared to stimulate or prolong LH release. Testosterone levels in CRH-treated animals were significantly lower than in controls both during and after CRH administration. In some instances, increases in plasma LH were not accompanied by a rise in testosterone. This would suggest that as was observed in restrained animals, stress exerts either a direct or an indirect inhibition of testicular testosterone secretion. The present data indicate that this effect may be mediated by CRH.
INTRODUCTION
Surgical [1] [2] [3] [4] [5] [6] , physical [7] [8] [9] [10] [11] [12] , and social stress [13] [14] [15] [16] [17] can result in decreased plasma levels of gonadotropin and/ or testosterone in men and in male nonhuman primates. In recent years, several studies have suggested that the hypothalamic peptide, corticotropin-releasing hormone (CRH), is involved in the inhibition of the hypothalamic-pituitarytesticular axis in response to noxious stimuli. In the rat, central administration of a CRI antagonist blocks the stressinduced inhibition of LH resulting from inescapable electroshock [18] . CRH also inhibits the release of GnRH into the pituitary-portal system in vivo [19] and from the isolated medial basal hypothalamus in vitro [20, 21] . In addition, anatomical evidence supporting the possible role of CRH in influencing secretion of GnRH, and therefore LH, has been provided by a study demonstrating direct synaptic connections between CRH and GnRH-containing neurons in the rat [22] . Physiological studies in primates indicate that unlike the situation in the rat, where peripherally administered CRH does not affect LH release, CRH peripherally administered can inhibit both the pulsatile release of LH [23, 24] and volleys of multiunit electrical activity in the medial basal hypothalamus that correspond with pulsatile LH release [25] . These findings are all consistent with the suggestion that stress influences reproductive function in part through its central action on the hypothalamic GnRH pulse generator. To examine the hypothesis that inhibition of the pituitary-testis axis by restraint stress is partially attributable to the action of CRH, we determined how peripheral CRH administration affected the pituitary-adrenal axis and the pituitary-testis axis by measuring plasma levels of ACTH, cortisol, LH, and testosterone in adult male rhesus macaques. These studies were conducted in the animals' home cages and in the absence of any acute stressor.
MATERIALS AND METHODS

Subjects
Nine adult male rhesus macaques (Macaca mulatta), 7-12 kg in weight, were housed in the same room in individual cages under temperature (23 ± 2°C)-and light-controlled conditions (lights-on: 0645-1845 h). Animals were maintained on a diet of monkey chow and fresh fruit, with tap water available ad libitum. Routine daily animal care and maintenance consisted of feeding from 0700 to 0900 h, cage cleaning from 0900 to 1000 h, and an unrestricted afternoon feeding at 1600 h. Fresh fruit was provided three times a week. Entry into the primate room was restricted to the animal caretakers and personnel involved in the research project.
Experimental Procedures
Each subject was fitted with a cranial prosthesis surgically attached to the calvaria with dental acrylic [26] . After at least 2 wk of recovery from surgery, each animal was tethered with a stainless steel cable to a swivel device attached to the top of the cage. When adapted to the tether, the animal was fitted with an indwelling cardiac catheter constructed from 18-gauge polyvinylchloride tubing. The catheter was introduced into the right atrium via the external or internal jugular vein. Once the catheter was positioned in the heart, its free end was tunneled s.c. to the cranial prosthesis and exteriorized via the tether unit. To allow remote collection of blood samples, an extension of the cardiac catheter attached to the swivel device at the top of the cage was passed through a small opening in the wall and connected to a three-way stopcock in the adjacent laboratory. Patency of the catheter was maintained by continuous infusion (0.6 ml/h) of heparinized physiological saline (10 U/ml).
On days when experiments were conducted, blood samples (1 ml) were collected through the indwelling catheter at 15-min intervals for 15 h beginning at 0700 h. The blood was immediately transferred from the plastic syringe into prechilled siliconized glass tubes containing 10 Il 14% EDTA During the course of each experiment, blood samples were centrifuged at 5-h intervals and the plasma was withdrawn and stored frozen at -20°C in polypropylene vials until assays were performed.
Human CRH (Bachem, Torrance, CA) was dissolved in sterile physiological saline (100 pg/5 ml) immediately before administration. After a 3-h period during which control samples were taken, a 100-pxg CRH bolus was administered through the indwelling catheter at 1000 h followed by a constant infusion of 100 Rg/h (8-14 Rpg/kg b.w.) for 4 h. This regimen of CRH was chosen because it has been shown to suppress LH release in ovariectomized rhesus macaques [23] . Blood samples were collected for an additional 8 h after CRH treatment ceased. Throughout the experiment, normal human traffic related to animal husbandry was permitted in the animal quarters. The experimental animals were otherwise not disturbed throughout the 15-h study.
Assays
Plasma ACTH was measured with an immunoradiometric assay (Allegro HS-ACTH; Nichols Institute, San Juan Capistrano, CA) that has been validated for human ACTH [27] . Since this assay utilizes two specific antibodies (a polyclonal antibody against the C-terminal region of ACTH and a monoclonal antibody against the N-terminal portion of ACTH) against different portions of ACTH, it detects only intact ACTH molecules. Although we did not perform an extensive validation for the ACTH assay for rhesus macaques, plasma from all animals in the present study showed binding that was parallel to the ACTH standard [12] .
Plasma concentrations of LH were measured in 5-or 10-Ip1 plasma aliquots with a Leydig cell bioassay [28] ; results are expressed as ng NICHHD rh LH RP-1(WDP-XV-20)/ml. Sensitivity of the assay was 0.1 ng LH with 10 pI; only an occasional sample fell below this level, and those points are plotted directly on the abscissa in the figures. Testosterone [29] and cortisol [30] were measured in plasma by established radioimmunoassays after samples were extracted with ether. 
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Data Analyses
Group cortisol, LH, and testosterone data, obtained by collapsing the plasma values for each animal across three intervals (0700-1000 h, 1000-1400 h, 1400-2200 h) based on the period of CRH administration (1000-1400 h), were submitted to split-plot analysis of variance (ANOVA). The independent component of the design consisted of controls and CRH-treated groups, and the repeated measures component consisted of the three time intervals indicated above.
RESULTS
Plasma levels of both ACTH and cortisol were elevated within a few samples after initiation of CRH infusion (Fig.  1, A-C) . ACTH was measured in only three animals. We measured this hormone primarily to document that the rise in cortisol secretion after CRH administration was associated with increased plasma levels of ACTH. Cortisol levels in CRH-treated subjects were significantly above those in controls, even in the initial control period; these levels continued to rise throughout the 4 h of CRH administration and remained significantly (F 2 14 = 35.19;p -0.0001) above levels observed in control animals throughout the remainder of the experiment (Fig. 2) . In the control group, however, cortisol showed a significant decrease during the 4-h period when experimental animals received CRH; the CRHtreated group showed a significant rise in cortisol during this same period (Fig. 2) . Since individual hormonal profiles for control animals have been presented in previous publications [12, 31] , they are not included in the present report.
In 4 of 5 animals, LH levels appeared to increase in response to CRH administration (Fig. 1, A-C) . LH was obviously suppressed during CRH administration in only one animal and remained low after CRH in one other animal. ANOVA of the LH group data showed no significant differences (F2, 14 = 0.37; p 0.6993) across the three time intervals investigated (before, during, and after CRH administration). However, as indicated in Figure 3 , the increase in LH that was observed in controls during the CRH administration period was diminished with CRH treatment.
Although LH levels were not significantly lower in CRHtreated animals, ANOVA of the group data revealed a significant inhibition of testosterone levels (F 2 , 1 4 = 4.32; p 0.0345) with CRH administration as compared to control treatment. Testosterone levels were not different between groups in the control period, but they were significantly lower in animals given CRH than in control animals both during and after the CRH treatment (Fig. 2) . Data from in-
Mean -SEM levels of LH, testosterone, and cortisol in control and CRH-treated animals before (0700-1000 h), during (1000-1400 h), and after (1400-2200 h) CRH administration. Asterisks (*) indicate means that are significantly different from those for controls. dividual animals (AJ 75, 12915) show that even when LH increased during the CRH administration period, testosterone levels did not always respond to that increase.
DISCUSSION
Since our recent studies showed that restraint stress caused an acute inhibition of LH release [12] and we surmised that CRH was the factor responsible for this inhibition, the lack of a significant effect on LH levels after CRH administration to nonstressed intact male rhesus macaques was unexpected. Previous studies have shown that peripheral CRH administration to ovariectomized macaques decreases both pulsatile LH release [23] and the frequency of pulse generator activity in the medial basal hypothalamus presumed to drive those LH pulses [25] . On the basis of those studies, we administered CRH to determine whether this hypophysiotropic peptide would duplicate the effects of restraint stress on gonadotropin release. In some individual animals, CRH appeared actually to stimulate or prolong LH release. However, in 3 of 5 animals, CRH appeared to inhibit the testicular testosterone response to increased LH levels, suggesting that CRH might have either a direct or an indirect (through ACTH, 13-endorphin, or cortisol) effect on the testes. This dampened testosterone response to gonadotropin is similar to the response to restraint stress observed in some animals [12] . As expected, ACTH and cortisol levels in CRH-treated animals were significantly elevated above control levels at the comparable time of day.
There are several straightforward explanations for the finding that peripheral CRH administration did not suppress LH release to the same extent as restraint stress and in some instances actually stimulated LH release or prolonged the LH pulse. The first explanation is that CRH did not cross the blood-brain barrier and therefore did not have access to the GnRH pulse generator. Although it is unlikely-because of its size (41 amino acids)-that CRH did cross the blood-brain barrier, previous studies have shown that peripheral administration of CRH can decrease the frequency of multiunit volleys from what is presumed to be the GnRH pulse generator within the medial basal hypothalamus. When this pulse generator is inhibited by CRH, there is a decrease in the temporally associated pulse of LH in ovariectomized macaques [23, 25] . However, since gonadal steroids can alter the morphology of the GnRH neuron and its immediate environment in both the preoptic area and medial basal hypothalamus [32, 33] , input to the GnRH neuron may be significantly altered in gonadectomized as compared to intact animals. This could modify both the direct and indirect influence of CRH on the pulse generator. It appears from the present study and other data from our laboratory [34] that gonadal steroids offer protection against the CRH-induced inhibition of LH release.
Another possible explanation for the differences in the LH response to CRH between intact and agonadal animals is that both of the studies in agonadal females were conducted in primate chairs similar to those we use to impose our restraint stress. Therefore, the central mechanisms that cause LH release in these chaired animals may have been under additional inhibitory tone, even though the animals were adapted to the restraint procedure. This interpretation is further supported by the observation that cortisol levels in the chair-restrained animals were generally above 25 [tg/dl [23] [24] [25] whereas cortisol levels in unrestrained animals at the morning peak are 15 jig/dl in intact and 10 ptg/dl in ovariectomized animals [35] .
Finally, from the present data, it appears that receiving a CRH infusion is not the same physiological experience as stress. Even though the cortisol levels after CRH infusion in intact male macaques were comparable to those observed during restraint [12] , it is most likely that the total experience of stress cannot be duplicated by CRH administration.
In the present study and in our previous report on the effects of restraint stress on the pituitary-testicular axis [12] , elevations of ACTH and cortisol were sometimes associated with suppressed testosterone levels in the face of increased LH levels. Acute elevations in cortisol levels in men can inhibit testosterone secretion without affecting LH or prolactin levels [36] : a 2-fold increase in circulating cortisol levels as a result of insulin-induced hypoglycemia was seen to result in a 20% reduction of testosterone levels within 90 151 E 0 C X min. Since LH levels were not affected by this treatment, adrenal activation may result in a direct inhibitory action on the testes. There are also indications of a direct action of restraint stress on the testes of male rats, in which testosterone levels are inhibited without affecting LH levels [37] . This ability of restraint stress to inhibit testosterone production may be by the direct action of glucocorticoids on testicular interstitial cells, since the inhibitory effects of glucocorticoids both in vivo and in vitro on Leydig cells can be partially blocked with RU486, a potent antiglucocorticoid [38] . The lack of a response to increased LH levels might also be explained by a glucocorticoid-mediated decrease in LH receptors as shown, for example, in the rat [39] .
CRH may also directly inhibit testosterone production by Leydig cells. Leydig cells secrete CRH in response to LH/ hCG, and incubation of these cells with an antagonist to CRH has suggested the possibility of tonic autocrine suppression of basal and stimulated testosterone production by CRH [40] . Inhibition of testosterone secretion has also been observed in response to infusions of two catecholamines, epinephrine and norepinephrine [41] , that are released from the adrenal medulla in response to stress.
These studies suggest that in animals with intact gonads, CRH may not be the sole agent responsible for inhibition of LH and testosterone secretion in response to stress. CRH appears to temporarily disrupt the pulsatile nature of LH release, but our data also suggest that this neuropeptide may actually stimulate the release of LH from the pituitary. Part of the inhibitory effect of stress and of CRH in males may result from a direct inhibition of testicular testosterone secretion. Evidence exists for both a direct action of CRH on Leydig cells and an indirect action through other hormones.
